Advanced Enzyme Technologies (540025)

Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally.

The market capitalization of Advanced Enzyme Technologies is currently at Rp32.78 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 3.83.

With one share of Advanced Enzyme Technologies investors achieved a dividend of Rp0.95. This results in a very low dividend yield of 0.27%. In the last 3 years, the annual dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.23. The price of the stock BSE:540025 is therefore subject to moderate fluctuations in relation to the overall market.

64.81% of 540025 Stocks is owned by insiders.

Since not enough Wall Street analysts have published their estimates, we are unfortunately unable to provide a reliable price target for the 540025 stock.

BSE:540025 has a 52 week range of Rp299.15 - Rp503.00 and is currently trading around Rp351.45.

The low short sale ratio indicated that the value might increase in the foreseeable future.